You are here:

NICE
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Lipid disorders

Lipid disorders Products

A list of all our products on lipid disorders

Filter

Product type

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHighly specialised technologies guidance

Status
1 selected

StatusPublishedIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Obicetrapib or obicetrapib–ezetimibe for treating primary heterozygous hypercholesterolaemia or mixed dyslipidaemia [ID6519]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC